ICICI Lombard Profit Rebounds 135% QoQ as Investment Income Offsets Underwriting Loss
The insurer's profit surged sequentially, but a deteriorating combined ratio and slower premium growth highlight the ongoing tension between investment gains and core underwriting pressure.
ICICI Lombard's Q2 FY27 profit jumped 135% from a weak prior quarter, driven by strong investment income. However, the core underwriting business remained under pressure with a combined ratio above 100%, squeezing margins.
For India's largest private general insurer, the September quarter was a story of two engines. A powerful surge in investment income drove a sharp profit recovery, while the core business of underwriting insurance policies continued to face headwinds. The result is a quarter where profit jumped 135% from a weak June period, but underlying profitability metrics softened.
The numbers show a clear recovery from a difficult Q1. Revenue rose 19.1% year-on-year to ₹8,220 crore, while profit grew 15.4% to ₹946 crore. The more telling comparison is sequential: profit more than doubled from ₹403 crore last quarter.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Period | Sep 2026 | Jun 2026 | Sep 2025 |
| Revenue (₹ Cr) | 8,220.0YoY +19% | 7,101.8 | 6,902.4 |
| Profit (₹ Cr) | 946.0YoY +15% | 403.2 | 819.5 |
| Net Profit Margin (%) | 11.5YoY -3.4% | 5.7 | 11.9 |
Why Profit Surged While Margins Shrank
The massive sequential profit jump was powered by the investment portfolio. According to reports from CNBC TV18 and Moneycontrol, investment income rose to ₹1,554 crore in Q2 from ₹1,249 crore a year ago, with capital gains more than doubling. This offset a significant deterioration in underwriting performance.
The company's combined ratio, a key measure of underwriting health where a figure above 100% indicates a loss, worsened to 107% from 105.1% a year ago, as reported by The Hindu BusinessLine. This pushed the underwriting loss up 79% to ₹318 crore. Consequently, the net profit margin contracted by 40 basis points year-on-year to 11.5%.
The Growth Engine Is Shifting
The top-line growth masks a nuanced picture. Gross direct premium income (GDPI) grew just 3% year-on-year in Q2, trailing the industry's 7% growth, per CNBC TV18. However, excluding the volatile crop and mass health segments, growth was a healthier 13.9%, ahead of the industry.
Live Chart
· ICICIGI
(BSE)
ISIN: INE765G01017
Two segments are driving this adjusted growth. Motor insurance grew 13% in the first half, keeping pace with the industry. The standout was retail health, which grew 64% in the quarter, nearly double the industry rate, boosting its market share to 5%.
How Long Can Investments Carry the Quarter?
The outlook hinges on whether underwriting discipline can catch up to premium growth. Management, in its earnings call, expects motor loss ratios to stay between 65-67% and retail health ratios between 65-70%. The solvency ratio remains strong at 2.74x, well above the regulatory minimum.
However, the industry backdrop is competitive. Reports from Insurance Business Mag note that motor growth remains volume-led with stable pricing, while commercial lines like fire insurance face intense price pressure. The proposed IRDAI norms on commission structures add another layer of uncertainty for distribution costs.
Key Points
- Profit rebounded 135% quarter-on-quarter, primarily fueled by a 24% rise in investment income and strong capital gains.
- The core underwriting business weakened, with the combined ratio deteriorating to 107%, leading to a 79% wider underwriting loss.
- Premium growth was bifurcated: overall growth lagged the industry, but retail health and motor (ex-crop) grew strongly, gaining market share.
- Management guidance points to stable target loss ratios in key segments, but competitive and regulatory pressures persist.
Hexa Perspective
The quarter underscores a classic insurance dilemma: investment gains can paper over underwriting weakness, but only for so long. The 40 bps year-on-year margin compression, despite a 19% revenue rise, signals that pricing and claims pressure are real.
The path forward depends on the retail health and motor segments maintaining their outperformance to offset softness in commercial lines. With the investment book providing a robust buffer, the company has time, but investors will watch for signs that the combined ratio can sustainably move toward the 100% break-even mark.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.